Abstract:Objective: Our objective was to evaluate serum phosphorus control in patients undergoing continuous ambulatory peritoneal dialysis, with and without residual renal function, by investigating the metabolic balance of phosphorus.Methods: We assessed serum phosphorus levels in 205 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The clinical factors related to serum phosphorus were also examined, including dietary phosphate intake, dietary protein intake (DPI), phosphate removal through urine and dialysate, doses of phosphorus binder and vitamin D, and serum intact parathyroid hormone (PTH) levels. Nutritional indexes, including serum albumin (Alb), lean body mass (LBM), hand-grip strength (HGS), and subjective global assessment (SGA), were also assessed. Dialysis adequacy and residual renal function (RRF) were calculated by a standard technique. Patients with RRF <2 mL/min were viewed as having no significant RRF Hyperphosphatemia was diagnosed in patients with serum phosphorus levels >1.78 mmol/L.Results: The mean serum phosphorus level of all patients was 1.6 +/- 0.5 mmol/L (mean +/- SD). Only 58 of 205 patients (28%) had hyperphosphatemia. The average DPI was 0.8 +/- 0.3 g/kg/d, whereas the average dietary phosphorus intake was 691 +/- 201 mg/d. There were no differences in mean serum phosphorus levels or incidents of hyperphosphatemia between patients with and without RRF (1.6 +/- 0.4 mmol/L vs. 1.7 +/- 0.5 mmol/L, P = .256; 22% vs. 31%, P = .336). Although total phosphorus removal through urine and dialysate was lower in the 115 patients without RRF than in the 90 patients with RRF (270 +/- 106 mg vs. 333 +/- 129 mg, P = .000), they simultaneously had a lower dietary phosphorus intake (656 +/- 191 mg vs. 713 +/- 215 mg, P = .046). In addition, patients without RRF had significantly lower DPI, Alb, LBM, and right HGS levels than patients with RRF (P < .01-.05). In those without RRF, the 79 patients without hyperphosphatemia had significantly lower DPI, LBM, and HGS levels, and a higher prevalence of malnutrition diagnosed by SGA, than the 36 patients with hyperphosphatemia (P < .001-.05). However, in patients with RRF, there was no difference in nutritional index between patients with and without hyperphosphatemia (P > .05).Conclusion: A relatively lower prevalence of hyperphosphatemia existed in CAPD patients both with and without RRF, which may be associated with incremental dialysis, the correct administration of phosphorus binder, and a lower protein and phosphorus intake. However, patients without RRF, especially those without hyperphosphatemia, ran the risk of malnutrition, despite a well-controlled phosphorus intake. (C) 2007 by the National Kidney Foundation, Inc.

Clinical factors associated with hyperphosphatemia in peritoneal dialysis patients

Dietary Phosphorus Intake and Distribution in Chinese Peritoneal Dialysis Patients with and Without Hyperphosphatemia

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Improving Diet Recipe and Cooking Methods Attenuates Hyperphosphatemia in Patients Undergoing Peritoneal Dialysis.

High Serum Phosphorus Level is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients

Disorders of calcium and phosphorus metabolism and influence factors in peritoneal dialysis patients.

Low Prevalence of Hyperphosphatemia Independent of Residual Renal Function in Peritoneal Dialysis Patients

Relationship between dietary phosphorus intake and nutritional status and calcium and phosphorus metabolism in patients with chronic kidney disease

Influence of Dietary Protein on Serum Phosphorous Levels in Peritoneal Dialysis Patients with Different Initial Transport Function.

The optimal ranges of serum calcium, phosphorus and intact parathyroid hormone in peritoneal dialysis patients

Calcium and Phosphonium Metabolism in Peritoneal Dialysis Patients with Different Dialysates

The risk factors for pulmonary hypertension in peritoneal dialysis patients

Mineral and Bone Disorder in Chinese Dialysis Patients: a Multicenter Study

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients

Peritoneal Phosphate Clearance: Determinants and Association With Mortality

Relationship between phosphorus and creatinine clearance in peritoneal dialysis: clinical implications

Clinical Analysis of Calcium and Phosphate Metabolism in Peritoneal Dialysis Patients

Effect of low-calcium and standard-calcium dialysate on serum calcium, phosphorus and full-segment parathyroid hormone in patients on peritoneal dialysis: A retrospective observational study

The related factors of pulmonary hypertension in peritoneal dialysis patients

Prevalence and Influencing Factors of Peritoneal Calcification in Patients with Long Peritoneal Dialysis Duration

Calcium and Phosphorus Balance in Chinese Continuous Ambulatory Peritoneal Dialysis Patients